Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 15;13(8):e17191.
doi: 10.7759/cureus.17191. eCollection 2021 Aug.

Mucocutaneous Manifestations of Inflammatory Bowel Disease

Affiliations
Review

Mucocutaneous Manifestations of Inflammatory Bowel Disease

Jose C Alvarez-Payares et al. Cureus. .

Abstract

Inflammatory bowel disease (IBD) is a chronic and incurable disease, of unknown etiology, associated with an unregulated immune response to environmental triggers in a genetically predisposed host. IBD affects mainly the gastrointestinal (GI) tract and includes Crohn's disease (CD) and ulcerative colitis (UC). However, a large percentage of patients may present with extraintestinal manifestations, including mucocutaneous ones (which are the most common) and dermatologic findings, such as erythema nodosum, pyoderma gangrenosum, and aphthous stomatitis (which are the most frequently occurring). According to pathophysiologic mechanisms, mucocutaneous manifestations of IBD are classified into five categories, namely, specific manifestations, associated manifestations, reactive manifestations, adverse effects of IBD therapy, and malabsorption manifestations. Recognizing such manifestations should not be performed only by a dermatologist but also other specialties such as internal medicine, gastroenterology, among others. This is because these manifestations can present before the IBD diagnosis, even in the absence of GI symptoms. Therefore, these skin lesions could be a fundamental tool for the earlier diagnosis of IBD. This review provides a comprehensive overview of the most common cutaneous manifestations of IBD with a focus on their epidemiology, diagnostic criteria, clinical presentation, and available medical treatment.

Keywords: cutaneous crohn’s disease; cutaneous manifestations of inflammatory bowel disease; extraintestinal manifestations in inflammatory bowel disease; inflammatory bowel disease; ulcerative colitis (uc).

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. A) Papa syndrome: Pyogenic arthritis. Edema, joint effusion, functional limitation of the knee; B-C) Papa syndrome: Acne. Post-inflammatory hyperpigmentation. Presence of facial erythema, erythematous papules, pustules, and atrophic scars type: boxed and ice pick. D) Papa syndrome: Pyoderma gangrenosum. Ulcer with a raised violet erythematous border, well-defined, with a yellowish background, painful on the front of the leg. E) Acquired epidermolysis bullosa. This clinical presentation is similar to bullous pemphigoid with tense bullae, erosions, and crusts over an erythematous base. Post-inflammatory hyperpigmentation is also observed. F) Pyoderma gangrenosum. The initial lesion is a non-follicular pustule, hemorrhagic, of rapid widening, surrounded by an erythematous strip. It’s very painful.
Images are courtesy of the Dermatology Department of the University of Antioquia, Colombia. All images had the consent of the patients.

References

    1. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: symptoms, extraintestinal manifestations, and disease phenotypes. Yu YR, Rodriguez JR. https://linkinghub.elsevier.com/retrieve/pii/S1055-8586(17)30106-3. Semin Pediatr Surg. 2017;26:349–355. - PubMed
    1. Early-onset inflammatory bowel disease. Kelsen JR, Russo P, Sullivan KE. https://linkinghub.elsevier.com/retrieve/pii/S1055-8586(17)30106-3. Immunol Allergy Clin North Am. 2019;39:63–79. - PMC - PubMed
    1. Inflammatory bowel disease. Shapiro JM, Subedi S, LeLeiko NS. Pediatr Rev. 2016;37:337–347. - PubMed
    1. Dermatologic manifestations of inflammatory bowel disease: a review. Keyal U, Liu Y, Bhatta AK. https://www.discoverymedicine.com/Uma-Keyal/2018/05/dermatologic-manifes... Discov Med. 2018;25(139):225–233. - PubMed
    1. Extraintestinal manifestations in inflammatory bowel disease - epidemiology, genetics, and pathogenesis. Greuter T, Vavricka SR. Expert Rev Gastroenterol Hepatol. 2019;13:307–317. - PubMed

LinkOut - more resources